Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pharming (PHAR) Tax Provisions (2020 - 2025)

Historic Tax Provisions for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to -$2.1 million.

  • Pharming's Tax Provisions rose 1722.92% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.4 million, marking a year-over-year decrease of 31852.7%. This contributed to the annual value of $3.3 million for FY2024, which is 32875.68% up from last year.
  • Per Pharming's latest filing, its Tax Provisions stood at -$2.1 million for Q3 2025, which was up 1722.92% from -$5.6 million recorded in Q2 2025.
  • Pharming's 5-year Tax Provisions high stood at $7.1 million for Q4 2021, and its period low was -$5.7 million during Q2 2021.
  • In the last 5 years, Pharming's Tax Provisions had a median value of -$750000.0 in 2022 and averaged -$408055.2.
  • As far as peak fluctuations go, Pharming's Tax Provisions soared by 21261.54% in 2023, and later plummeted by 172292.99% in 2024.
  • Over the past 5 years, Pharming's Tax Provisions (Quarter) stood at $7.1 million in 2021, then tumbled by 118.38% to -$1.3 million in 2022, then soared by 212.62% to $1.5 million in 2023, then tumbled by 271.72% to -$2.5 million in 2024, then rose by 16.11% to -$2.1 million in 2025.
  • Its Tax Provisions was -$2.1 million in Q3 2025, compared to -$5.6 million in Q2 2025 and -$3.1 million in Q1 2025.